• Pawelec G, Müller CA, Haen M, Schaudt K, Ehninger G: Lack of association between the frequencies of HLA-DR or HLA-DP alleles and the occurence of chronic graft versus host disease. Transplantation, 51:917,1991
  • Pawelec G: Modulation of interleukin-2 and interleukin-4-induced cytotoxicities in human helper T-lymphocyte clones by tumor necrosis factor- . J Immunol, 146:572, 1991
  • Hamann W, Bruserud O, Patel S, Schmidt H, Ehninger G, Pawelec G: Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantation. Bone Marrow Transplantation 8:113, 1991
  • Bruserud O, Elsayed S, Pawelec G: At least five antigenic epitopes on the streptokinase molecule are recognized by human CD4+ TCR /ß+ T cells. Mol Immunol 29:1097, 1992
  • Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawelec G: Analysis of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of the synovial tissue. Ann Rheum Dis, 51:731, 1992
  •  Fernandez N, Kurpisz M, Sachs J, Labeta M, Pawelec G: A ligand-epitope in vitro analysis of MHC determinants expressed on B and T lymphocytes. Immunol 77:116, 1992
  • Reuss-Borst MA, Pawelec G, Saal JG, Horny HP, Müller CA, Waller HD: Sweet´s Syndrome associated with myelodysplasia - possible role of cytokines in the pathogenesis of the disease. B J Haematol 84:356, 1993 
  • Friccius H, Siegels-Hübenthal P, Rehbein A, Schlotz E, Pawelec G: Induction of hyporesponsiveness in human lymphocytes-T despite their expression of both the coreceptor CD28 and its ligand B7. Cell Immunol 151:283, 1993
  • Adibzadeh M, Bühring HJ, Daikeler T, Siegels-Hübenthal P, Owsianowsky M, Schenk A, Rehbein A, Schaudt K, Schlotz E, Pohla H, Pawelec G: Extrathymic development and function of human T- lymphocytes from bone marrow cells in vitro. Cell Immunol 154:25, 1994
  • Adibzadeh M, Friccius H, Bornhak S, Max H, Hambrecht A, Sansom D, Kalbacher H, Schenk A, Pohla H, Pawelec G: Role of three quantitatively dominant endogenous peptides from HLA- DRB1*0401 molecules in class II-specific alloreactivity. Transplant Immunol 2:293, 1994
  • Pawelec G, Friccius H, Boshell M, Rehbein A, Schlotz E, Pohla H, Schaudt K, Sansom D: Human T cells are resistant to anergy induction but not clonal deletion in vitro. Cell Immunol 162:8, 1995
  • Bruserud O, Gjertsen BT, Brustugun OT, Bassoe CF, Nesthus I, Akselsen PE, Bühring HJ, Pawelec G: Effects of Interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 9:1910, 1995
  • Adibzadeh M, Pohla H, Rehbein A, Pawelec G: Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech Ageing Dev 83:171, 1995
  • Pawelec G, Max H, Halder T, Bruserud O, Merl A, Da Silva P, Kalbacher H: BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood 88:2118, 1996 47)
  • Pawelec G, Rehbein A, Schlotz E, Friccius H, Pohla H: Cytokine modulation of Th1/Th2 phenotype differentiation in directly alloresponsive CD4+ human T cells. Transplantation 62:1095, 1996 48)
  • Pawelec G, Sansom D, Rehbein A, Adibzadeh M, Beckman I: Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp Gerontol. 31:655, 1996
  • Adibzadeh M, Mariani E, Bartoloni C, Beckman I, Ligthart G, Remarque E, Shall S, Solana R, Taylor GM, Barnett Y, Pawelec G: Lifespans of T lymphocytes. Mech Ageing Dev 91:145, 1996
  • Pawelec G, Hambrecht A, Rehbein A, Adibzadeh M: Interleukin 10 protects activated human T lymphocytes against growth factor withdrawal-induced cell death but only anti-fas antibody can prevent activation-induced cell death. Cytokine 8:877, 1996
  • Li K, Heinzel S, Halder T, Zeuthen J, Müller C, Adibzadeh M, Kalbacher H, Pawelec G: Autocrine proliferative responses to native melanoma cells by MHC class II-restricted T cells sensitized in vitro to synthetic peptides of gp100 and Annexin II. Cancer Immunol Immunother 47: 32, 1998
  • Halder T, Pawelec G, Kirkin A F, Zeuthen J, Meyer HE, Li K, Kalbacher H: Novel class II-restricted melanoma antigens. Cancer Res. 57:3238, 1997
  • Pawelec G, Müller R, Rehbein A, Hähnel, K, Ziegler B: Extrathymic T cell differentiation in vitro from human CD34+ stem cells. J Leuk Biol 64:733, 1998
  • Pawelec G, Müller R, Rehbein A, Hähnel, K, Ziegler B: Finite lifespans of T cell clones derived from CD34+ human haematopoietic stem cells in vitro. Exp Gerontol 34:69, 1999
  • Potestio M, Pawelec G, DiLorenzo G, Candore G, D´Anna C, Gervasi F, Lio D, Tranchida G, Caruso C, Romano GC: Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes. Exp Gerontol 34:659, 1999
  • Halder TM, Blüggel M, Heinzel S, Pawelec G, Meyer HE, Kalbacher H: Defensins are Dominant HLA-DR-Associated Self Peptides from CD34-Peripheral Blood Mononuclear Cells of Different Tumor Patients (Plasmacytoma, Chronic Myeloid Leukemia). Blood 95:2890, 2000